• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Downregulation of MHC Class I Expression by Influenza A and B Viruses

tetano

Editor, Senior Moderator
Front Immunol. 2019 May 29;10:1158. doi: 10.3389/fimmu.2019.01158. eCollection 2019.
[h=1]Downregulation of MHC Class I Expression by Influenza A and B Viruses.[/h] Koutsakos M[SUP]1[/SUP], McWilliam HEG[SUP]1,[/SUP][SUP]2[/SUP], Aktepe TE[SUP]1[/SUP], Fritzlar S[SUP]1[/SUP], Illing PT[SUP]3[/SUP], Mifsud NA[SUP]3[/SUP], Purcell AW[SUP]3[/SUP], Rockman S[SUP]1,[/SUP][SUP]4[/SUP], Reading PC[SUP]1,[/SUP][SUP]5[/SUP], Vivian JP[SUP]3,[/SUP][SUP]6[/SUP], Rossjohn J[SUP]3,[/SUP][SUP]6,[/SUP][SUP]7[/SUP], Brooks AG[SUP]1[/SUP], Mackenzie JM[SUP]1[/SUP], Mintern JD[SUP]2[/SUP], Villadangos JA[SUP]1,[/SUP][SUP]2[/SUP], Nguyen THO[SUP]1[/SUP], Kedzierska K[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Manipulation of the MHC-I presentation pathway, and thus limiting MHC-I cell surface expression, is used by many viruses to evade immune recognition. In particular, downregulation of MHC-I molecules at the cell surface can reduce the ability of CD8[SUP]+[/SUP] T cells to recognize viral peptides presented by MHC-I molecules and thereby delay viral clearance by CD8[SUP]+[/SUP] T cells. To date, MHC-I downregulation by influenza viruses has not been reported. Given that influenza virus infections are a global health concern and that CD8[SUP]+[/SUP] T cells play an important role in promoting influenza virus clearance and recovery from influenza disease, we investigated whether influenza A and B viruses (IAV, IBV) downregulated MHC-I as a novel mechanism to evade cellular immunity. Here, we showed that infection of several cell types, including epithelial A549 cells, with a panel of IAV and IBV viruses downregulated the surface MHC-I expression on IAV/IBV-infected cells during the late stages of influenza virus infection in vitro. This observation was consistent across a panel of class I-reduced (C1R) cell lines expressing 14 different HLA-A or -B alleles and a panel of 721.221 cell lines expressing 11 HLA-C alleles. Interestingly, IBV infection caused more pronounced reduction in surface MHC-I expression compared to IAV. Importantly, the two viruses utilized two distinct mechanisms for MHC-I downregulation. Our data demonstrated that while IAV caused a global loss of MHC-I within influenza-infected cells, IBV infection resulted in the preferential loss of MHC-I molecules from the cell surface, consequent of delayed MHC-I trafficking to the cell surface, resulting from retaining MHC-I intracellularly during IBV infection. Overall, our study suggests that influenza viruses across both IAV and IBV subtypes have the potential to downregulate MHC-I surface expression levels. Our findings provide new insights into the host-pathogen interaction of influenza A and B viruses and inform the design of novel vaccine strategies against influenza viruses.


[h=4]KEYWORDS:[/h] HLA; MHC-I; T cells; influenza A virus; influenza B virus

PMID: 31191533 PMCID: PMC6548845 DOI: 10.3389/fimmu.2019.01158
 
Back
Top Bottom